Safety paramount to COVID-19 vaccine programme
Comment from Royal Pharmaceutical Society: safety of staff and patients paramount to the COVID-19 vaccine programme: Following the news that…
Comment from Royal Pharmaceutical Society: safety of staff and patients paramount to the COVID-19 vaccine programme: Following the news that…
Urgent action needed on BAME workforce risk assessments: According to a new survey from the Royal Pharmaceutical Society (RPS) and…
This website uses cookies.